Drug Type Small molecule drug |
Synonyms ASP 4132, ASP4132 |
Target |
Mechanism AMPK agonists(AMP activated protein kinase agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Advanced cancer | Phase 1 | US | 23 Mar 2015 | |
Lymphoma | Phase 1 | US | 23 Mar 2015 | |
Solid tumor | Phase 1 | US | 23 Mar 2015 |
Phase 1 | 39 | oczutsxqwo(birmnquivb) = fatigue, mental status changes, dizziness, lactic acidosis, enteritis, and posterior reversible encephalopathy syndrome were observed in higher dose cohorts (7.5-mg and intermittent 10-mg and 15-mg dose cohorts) bwutwqmxkf (gzwisztxkc ) | Negative | 01 Oct 2021 |